Blood platelets as a model for monoamine-containing neurones.
D000342:Affective Symptoms / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001321:Autistic Disorder / Q000378:metabolism; D001679:Biogenic Amines / Q000378:metabolism*; D001692:Biological Transport; D001693:Biological Transport, Active / Q000187:drug effects; D001792:Blood Platelets / Q000502:physiology*; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism / Q000502:physiology; D002490:Central Nervous System / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004314:Down Syndrome / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008607:Intellectual Disability / Q000378:metabolism; D008094:Lithium / Q000494:pharmacology; D008954:Models, Biological; D008996:Monoamine Oxidase Inhibitors / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D010661:Phenylketonurias / Q000378:metabolism; D012701:Serotonin / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology
D000596:Amino Acids; D000928:Antidepressive Agents; D001679:Biogenic Amines; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D008094:Lithium; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine